Evercore ISI reiterated their outperform rating on shares of UnitedHealth Group (NYSE:UNH) in a research note released on Friday, MarketBeat reports. The brokerage currently has a $255.00 target price on the healthcare conglomerate’s stock, up from their prior target price of $235.00.

UNH has been the subject of several other reports. Leerink Swann reissued a buy rating and issued a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Zacks Investment Research raised UnitedHealth Group from a hold rating to a buy rating and set a $219.00 price objective for the company in a report on Thursday, September 21st. Cantor Fitzgerald increased their price objective on UnitedHealth Group to $225.00 and gave the company an overweight rating in a report on Wednesday, October 18th. Oppenheimer increased their price objective on UnitedHealth Group from $215.00 to $205.00 and gave the company an outperform rating in a report on Wednesday, October 18th. Finally, Wells Fargo & Co reissued an outperform rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. The company has a consensus rating of Buy and an average target price of $229.54.

UnitedHealth Group (NYSE UNH) opened at $228.64 on Friday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $221,060.00, a P/E ratio of 25.98, a P/E/G ratio of 1.54 and a beta of 0.66. UnitedHealth Group has a fifty-two week low of $156.09 and a fifty-two week high of $231.77.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company posted $2.17 earnings per share. equities analysts anticipate that UnitedHealth Group will post 9.99 EPS for the current fiscal year.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Thomas E. Roos sold 975 shares of the stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock valued at $7,669,416 in the last 90 days. Company insiders own 0.89% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the business. KCS Wealth Advisory acquired a new stake in UnitedHealth Group in the fourth quarter valued at $822,000. Broadleaf Partners LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $2,527,000. Bristol Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $463,000. Independence Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $214,000. Finally, Appleton Partners Inc. MA grew its holdings in UnitedHealth Group by 3.4% in the fourth quarter. Appleton Partners Inc. MA now owns 31,416 shares of the healthcare conglomerate’s stock valued at $6,926,000 after purchasing an additional 1,039 shares during the last quarter. Hedge funds and other institutional investors own 86.09% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Evercore ISI Reaffirms Outperform Rating for UnitedHealth Group (UNH)” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.dailypolitical.com/2018/01/16/evercore-isi-reaffirms-outperform-rating-for-unitedhealth-group-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.